Catalysts
PRODUCTS
-
The AMP30008 is a rugged, compact, and lightweight solid state high power pulse amplifier designed for demanding L-Band radar applications.
-
Pharmaceutical Checkweighing systems weigh and count products in motion, rejecting those that fail to meet exacting specifications.
-
Introducing the TITANITE lens series, a groundbreaking innovation in light sheet microscopy designed for high magnification and an expansive field of view.
-
Access, interact with, and even adjudicate clinical trial imaging from the same platform where you manage all other study data.
-
Antibody drug conjugates (ADCs) are the emerging class of anti-cancer therapeutic drugs. ADCs combine an antibody capable of recognizing cancer cells and cytotoxic small-molecule drugs via cleavable or non-cleavable linkers, thereby transforming the 3-unit combination into a targeted therapeutic drug for cancer treatment. In recent years, ADCs have rapidly developed and there are not only more than 14 approved drugs on the market but also many investigational drugs undergoing clinical trials. Furthermore, ADCs have shown potential for treating various diseases beyond cancer, such as Autoimmune disorders, Infectious diseases, Inflammatory conditions and so on.
WHITE PAPERS AND CASE STUDIES
-
Pasteurized Equivalent Water Treatment At High Desert Milk, Idaho, US
Learn how High Desert Milk, a cooperative in Idaho, optimized their water treatment process using HOD™ UV technology, ensuring FDA compliance while significantly reducing water and energy consumption.
-
Vaccine Trial Sees >90% eCOA Adherence
Discover how we addressed vaccine trial challenges and drove remarkable success, achieving over 90% adherence to eCOA, ensuring active engagement from the trial participants, and yielding consistent, reliable trial data.
-
82 Million Gallons In. Zero PFAS Out.
Ion exchange resin is a reliable, high-capacity solution for municipal PFAS treatment, demonstrating zero detectable PFAS after processing 82 million gallons of water. The technology offers a significantly smaller footprint and superior volumetric capacity compared to GAC. Read the full case study to review performance data and strategic impacts.
-
Modelling TPDs Utilizing Computational And Medicinal Chemistry Approaches
Through a carefully executed strategy, see how we identified novel degrader molecules with the right physicochemical properties to achieve robust degradation of the target Protein of Interest (POI).
-
SL-RAT At Little Rock Water Reclamation Authority
Little Rock looked to enhance their sophisticated cleaning program and reduce sanitary sewer overflow count by implementing new technologies.
-
Optimizing Chronic Cough Phase 3 Trials With Point-Of-Need Eye Assessments
Collaboration was key for Company W to overcome challenges with an FDA-mandated ocular substudy, including limited resources for ocular assessments and logistical difficulties
-
Leeton Shire Improves Efficiency And Service Levels With An Affordable, Intuitive Digital Solution
Although Leeton Shire already had some digital technologies in place, such as SCADA, GIS and AMI, they lacked hydraulic modeling capabilities and expertise — which is why they turned to Qatium’s open and secure water management platform.
-
Using eConsent Data To Populate Site And Sponsor Data Systems
A top-10 pharmaceutical company was looking to reduce the amount of administrative burden on their clinical trial sites and themselves. See how we accomplished it, using eConsent.
-
Standardize Flow Cytometry Data With Easy Assay Transfer Across Sites
Gain insight into how a global pharmaceutical company successfully transferred their cell therapy assays across international locations.
-
Driving A High-Adherence LTFU Trial Without An EDC
Discover how our partnership with a client was able to deliver a ten-year long-term follow-up (LTFU) trial that delivered an over 90% adherence rate while keeping trial costs low by not using an EDC.
-
Generation Of A Contamination Control Strategy
An unaddressed compliance issue related to contamination control can pose a significant risk to a life sciences organization. This case study details a company's journey toward sustainable compliance.
-
Rapid Assessment Of Fab-VHH Expression
Find out how a 10-day expression screening program rapidly identified optimal gene orientation for a bi-specific antibody fragment fusion, achieving up to 570 µg/mL soluble, active product.
NEWS
-
Researchers Develop New Design And Fabrication Method To Make Lightsails For Interstellar Travel3/27/2025
Since its launch in 1977, NASA’s Voyager 1 spacecraft has traveled over 15 billion miles into deep space.
-
Researchers Uncover Role Of A-Site Cation Ordering In Perovskite Anodes For High-Temperature Oxygen Evolution7/28/2025
Solid oxide electrolysis cells (SOECs) are a leading technology for carbon dioxide reduction and energy conversion, offering high current densities, excellent Faradaic efficiency, and low overpotentials. Perovskite oxides are commonly used as SOEC anodes, yet the impact of A-site cation ordering on their oxygen evolution reaction (OER) kinetics remains unexplored.
-
Climate Extremes In 2024 'Wreaking Havoc' On The Global Water Cycle1/6/2025
2024 was another year of record-breaking temperatures, driving the global water cycle to new climate extremes and contributing to ferocious floods and crippling droughts, a new report led by The Australian National University (ANU) shows.
-
Hamamatsu Photonics Launches The Next Generation In InGaAs APD9/16/2025
Hamamatsu Photonics is proud to announce the release of the G15978-0020P, a new InGaAs photodiode (InGaAs APD) representing the next step in miniaturized sensor technology.
-
Ready-To-Use hiPSC-Derived Cells Help Optimize Lab Workflows2/18/2025
AMSBIO announces a new range of ready-to-use Human induced Pluripotent Stem Cell (hiPSC) -derived cardiomyocytes, hepatocytes, and neurons.
ABOUT
Catalysts
Catalysts work by changing the structure of a molecule or by bonding to reactant molecules causing them to combine, react, and release a product or energy. For example, a catalyst is required in order for oxygen and hydrogen to bond, combine and produce water.
Catalysts increase the rate of chemical reactions. Unlike a reagent that gets consumed as apart of the chemical reaction, catalysts do not get consumed in the reaction. They can actually participate in multiple chemical transformations.Catalysts can be organic, synthetic or metal.
All processes need energy to take place. Processes require a very high level of energy in order to spark or start if a catalyst isn’t present. When a catalyst is present the amount of energy required to spark the reaction is lowered and that makes the reaction happen faster and more efficiently.
Catalytic effects vary depending on other substances present that are a part of the chemical reactions. There are certain substances that can inhibit the effectiveness of a catalyst like poisons, and other substances that promote or increase the effect of the catalyst. Inhibitors or negative catalysts are very important in medicine to treat mental illnesses, high blood pressure, cancer and many other diseases.
Catalysts are often used to help crack, or split, larger organic molecules like hydrocarbons into simpler molecules. It does this by breaking carbon-carbon bonds. The speed of the splitting process depends heavily on what specific catalyst is used and the temperature. Applications of this technology include oil and petrochemical industries.